Spark Therapeutics Reports Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Spark Therapeutics (ONCE) Misses Q2 EPS by 35c
August 5, 2015 8:47 AM EDTSpark Therapeutics (NASDAQ: ONCE) reported Q2 EPS of ($0.60), $0.35 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $1.29 million versus the consensus estimate of $4.5 million.
"During the past quarter we've made great strides in advancing our clinical programs and we... More
